LALPATHLAB.NS
LALPATHLAB.NS
INE600L01024
DR. LAL PATH LABS LTD.
Loading chart...

Company Profile

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

Related stocks

SAILIFE.NS
SAILIFE.NS • India
SAI LIFE SCIENCES LIMITED
1,487.9 INR
3.27B USD 1Y +74.7%
SYNGENE.NS
SYNGENE.NS • India
SYNGENE INTERNATIONAL LTD
347.4 INR
1.44B USD 1Y -45.1%
VIJAYA.NS
VIJAYA.NS • India
VIJAYA DIAGNOSTIC CEN LTD
1,436.6 INR
1.53B USD 1Y +44.5%
METROPOLIS.NS
METROPOLIS.NS • India
METROPOLIS HEALTHCARE LTD
529.25 INR
1.13B USD 1Y +4.2%
3347.HK
3347.HK • China
TIGERMED
44.56 HKD
4.89B USD 1Y +3.2%
603882.SS
603882.SS • China
GUANGZHOU KINGMED DIAGNOSTICS G
28.82 CNY
2B USD 1Y -3.4%
THYROCARE.BO
THYROCARE.BO • India
Thyrocare Technologies Limited
499 INR
820.66M USD 1Y +22%
300676.SZ
300676.SZ • China
BGI GENOMICS
45.47 CNY
2.85B USD 1Y -9.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.6% p.a.
Max Drawdown (5Y)
-54.2%
Sharpe Ratio (5Y)
-0.06
Beta Factor
0.16
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 59.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -57.7% in the extended horizon.
ende